Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6830318 | Seizure | 2016 | 54 Pages |
Abstract
The clinical experience captured suggests that clusters of clinical features associate well with specific NSAbs. Intensive and early immunotherapy is indicated when patients present with autoantibody-associated encephalopathies. It remains unclear how patients with chronic epilepsy and the same autoantibodies should be assessed and treated. Tables in this paper provide a comprehensive resource for systematic descriptions of both clinical features and treatments, and highlight limitations of current studies.
Keywords
Related Topics
Life Sciences
Neuroscience
Behavioral Neuroscience
Authors
Ochuko D. Bakpa, Markus Reuber, Sarosh R. Irani,